TherapeuticsMD Inc (NASDAQ:TXMD) has a bull cheering on back of news the drug maker is resubmitting its NDA to the FDA for vaginal …
TX-004 is on the path to FDA approval; Cantor’s William Tanner Sees 450% Upside.
Oppenheimer analyst Jay Olson is out with a bullish research note on TherapeuticsMD Inc (NYSEMKT:TXMD), after a positive independent observational study conducted by the …
Cantor analyst William Tanner is out today with a few insights on TherapeuticsMD Inc (NYSEMKT:TXMD), after the drug maker announced the publication of a manuscript …
Largely dismissing investor skepticism questioning the viability of TherapeuticsMD Inc (NYSEMKT:TXMD) vaginal soft gel capsule TX-004, analyst William Tanner of Cantor is confident …
Bank of America: Net Interest Income is Only Half the Story Bank of America Corp (NYSE:BAC) delivered better-than-expected second-quarter results, posting EPS of $0.46 compared …
Cantor analyst William Tanner is out with a research note on shares of TherapeuticsMD Inc (NYSEMKT:TXMD), after the company provided an update regarding the New Drug Application …
When looking at this week’s movers and shakers on the Street, Cantor analysts are backing their Buys on Oncomed Pharmaceuticals Inc (NASDAQ:OMED) and …
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) was up 9% in pre-market trading this morning following positive data from its CD19-specifict CAR T-cell therapy programs.
